The CEO's substantial personal investment suggests strong conviction ahead of potential catalysts; traders should monitor for upcoming clinical updates or partnerships.
Price Chart
Executive Summary
Generate Biomedicines CEO Michael Nally led a $240,000 open-market share purchase, joined by three other executives in smaller buys, signaling strong insider confidence. The cluster includes several non-cash derivative conversions with no economic impact.
Key Financial Metrics
Key Facts
- CEO Michael Nally purchased 20,000 shares for $240,000 in open-market transactions on March 4, 2026.
- President & CFO Jason Silvers, Chief People Officer Beth Grous, and Jane Mendillo each made open-market purchases totaling $36,800 combined.
- Four derivative conversions (totaling over 26 million shares) were non-cash events with $0 transaction value and no economic significance.
- Total open-market buying in the cluster: $277K across 4 insiders, matching recent 30-day insider activity.
- Insider purchases represent approximately 0.017% of the company's $1.6B market cap — modest in size but highly concentrated among C-suite executives.
Financial Impact
$277,000 in net insider buying over 7 days, all by corporate insiders at C-suite level
Risk Factors
- The dollar amount, while meaningful for insider activity, is small relative to market cap and unlikely to move the stock directly.
- No accompanying fundamental news or guidance update in this filing window.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CONTEXT: Insider Cluster Data (8 trades, 7d window) | cluster-GENB-1772834153988 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
May 7, 2026 21w ago | 8-K | $13.59 $14.34 | ▼ −5.52% | ▼ −1.69% | $13.54 (+0.37%) |
Mar 2, 2026 30w ago | Insider Cluster | $12.17 $13.34 | ▲ +9.61% | ▲ +0.29% | $13.54 (+11.26%) |
Mar 2, 2026 30w ago | Insider Cluster | $12.17 $13.34 | ▲ +9.61% | ▲ +0.29% | $13.54 (+11.26%) |
Feb 27, 2026 30w ago | 424B4 | $12.17 $13.34 | ▼ −9.61% | ▼ −0.29% | $13.54 (−11.26%) |
Feb 27, 2026 31w ago | EFFECT | $12.65 $13.34 | ▲ +5.45% | ▼ −3.93% | $13.54 (+7.04%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access